scispace - formally typeset
Search or ask a question
Institution

University of New South Wales

EducationSydney, New South Wales, Australia
About: University of New South Wales is a education organization based out in Sydney, New South Wales, Australia. It is known for research contribution in the topics: Population & Poison control. The organization has 51197 authors who have published 153634 publications receiving 4880608 citations. The organization is also known as: UNSW & UNSW Australia.


Papers
More filters
Journal ArticleDOI
01 Jan 2019-Pain
TL;DR: The goal here is to create a classification that is useful in both primary care and specialized pain management settings for the development of individualized management plans, and to assist both clinicians and researchers by providing a more accurate description of each diagnostic category.
Abstract: This article describes a proposal for the new diagnosis of chronic primary pain (CPP) in ICD-11. Chronic primary pain is chosen when pain has persisted for more than 3 months and is associated with significant emotional distress and/or functional disability, and the pain is not better accounted for by another condition. As with all pain, the article assumes a biopsychosocial framework for understanding CPP, which means all subtypes of the diagnosis are considered to be multifactorial in nature, with biological, psychological, and social factors contributing to each. Unlike the perspectives found in DSM-5 and ICD-10, the diagnosis of CPP is considered to be appropriate independently of identified biological or psychological contributors, unless another diagnosis would better account for the presenting symptoms. Such other diagnoses are called "chronic secondary pain" where pain may at least initially be conceived as a symptom secondary to an underlying disease. The goal here is to create a classification that is useful in both primary care and specialized pain management settings for the development of individualized management plans, and to assist both clinicians and researchers by providing a more accurate description of each diagnostic category.

541 citations

Journal ArticleDOI
TL;DR: In this paper, a review of the use of self-assembled monolayers (SAMs) for modifying electrodes with an emphasis on the development of integrated molecular systems is presented.
Abstract: The modification of an interface on a molecular level with more than one molecular ‘building block' is essentially an example of the ‘bottom–up' fabrication principle of nanotechnology. The fabrication of such integrated molecular systems in electrochemistry has seen rapid progress in recent years via the development of sensing interfaces fabricated using self-assembled monolayers (SAMs). This review outlines recent advances and applications of self-assembled monolayers for modifying electrodes with an emphasis on the development of integrated molecular systems. First, some basic issues regarding fabricating integrated molecular systems, such as the role of the surface topography of the electrode and patterning surfaces, are discussed. Subsequently an overview of recent developments in pH, inorganic and bio sensing involving the use of SAMs is given. Finally emerging trends in using molecular building blocks in the fabrication of integrated molecular systems, such as nanotubes, dendrimers and nanoparticles, are reviewed.

541 citations

Journal ArticleDOI
21 Sep 1995-Nature
TL;DR: It is reported that rapsyn is essential for the formation of AChR clusters, but that synapse-specific transcription of A ChR subunit genes can proceed in its absence.
Abstract: OF numerous synaptic components that have been identified, perhaps the best-studied are the nicotinic acetylcholine receptors (AChRs) of the vertebrate neuromuscular junction1. AChRs are diffusely distributed on embryonic myotubes, but become highly concentrated (~ 10,000 µm-2) in the postsynaptic membrane as development proceeds. At least two distinct processes contribute to this accumulation. One is local synthesis: subsynaptic muscle nuclei transcribe AChR subunit genes at higher rates than extra-synaptic nuclei, so AChR messenger RNA is concentrated near synaptic sites2,3. Second, once AChRs have been inserted in the membrane, they form high-density clusters by tethering to a sub-synaptic cytoskeletal complex. A key component of this complex is rapsyn, a peripheral membrane protein of relative molecular mass 43K (refs 4, 5), which is precisely colocalized with AChRs at synaptic sites from the earliest stages of neuromuscular synaptogenesis6. In heterologous systems, expression of recombi-nant rapsyn leads to clustering of diffusely distributed AChRs, suggesting that rapsyn may control formation of clusters7,8. To assess the role of rapsyn in vivo, we generated and characterized mutant mice with a targeted disruption of the Rapsn gene. We report that rapsyn is essential for the formation of AChR clusters, but that synapse-specific transcription of AChR subunit genes can proceed in its absence.

541 citations

Journal ArticleDOI
TL;DR: 5-dimension digital twin model provides reference guidance for understanding and implementing digital twin, and the frequently-used enabling technologies and tools for digital twin are investigated and summarized to provide Technologies and tools references for the applications of digital twin in the future.

541 citations

Journal ArticleDOI
TL;DR: Treatment with evacetrapib did not result in a lower rate of cardiovascular events than placebo among patients with high‐risk vascular disease, and had favorable effects on established lipid biomarkers.
Abstract: BackgroundThe cholesteryl ester transfer protein inhibitor evacetrapib substantially raises the high-density lipoprotein (HDL) cholesterol level, reduces the low-density lipoprotein (LDL) cholesterol level, and enhances cellular cholesterol efflux capacity We sought to determine the effect of evacetrapib on major adverse cardiovascular outcomes in patients with high-risk vascular disease MethodsIn a multicenter, randomized, double-blind, placebo-controlled phase 3 trial, we enrolled 12,092 patients who had at least one of the following conditions: an acute coronary syndrome within the previous 30 to 365 days, cerebrovascular atherosclerotic disease, peripheral vascular arterial disease, or diabetes mellitus with coronary artery disease Patients were randomly assigned to receive either evacetrapib at a dose of 130 mg or matching placebo, administered daily, in addition to standard medical therapy The primary efficacy end point was the first occurrence of any component of the composite of death from car

540 citations


Authors

Showing all 51897 results

NameH-indexPapersCitations
Ronald C. Kessler2741332328983
Nicholas G. Martin1921770161952
John C. Morris1831441168413
Richard S. Ellis169882136011
Ian J. Deary1661795114161
Nicholas J. Talley158157190197
Wolfgang Wagner1562342123391
Bruce D. Walker15577986020
Xiang Zhang1541733117576
Ian Smail15189583777
Rui Zhang1512625107917
Marvin Johnson1491827119520
John R. Hodges14981282709
Amartya Sen149689141907
J. Fraser Stoddart147123996083
Network Information
Related Institutions (5)
University of Melbourne
174.8K papers, 6.3M citations

97% related

University of Manchester
168K papers, 6.4M citations

94% related

McGill University
162.5K papers, 6.9M citations

93% related

University College London
210.6K papers, 9.8M citations

93% related

University of British Columbia
209.6K papers, 9.2M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023389
20221,183
202111,342
202011,235
20199,891
20189,145